Eurofins Scientific logo
Eurofins Scientific
ERFSF | OTC
Chart Builder DCF Calculator
$97.49
+$0.71 (+0.73%)
At close: Nov 16, 2026, 3:54 PM ET
$97.49
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET

Eurofins Scientific Income Statement

Income statement explained
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q4 2025
Dec 31, 2025
Q2 2025
Jun 30, 2025
Q4 2024
Dec 31, 2024
Q2 2024
Jun 30, 2024
Q4 2023
Dec 31, 2023
Q2 2023
Jun 30, 2023
Q4 2022
Dec 31, 2022
Q2 2022
Jun 30, 2022
Q4 2021
Dec 31, 2021
Q2 2021
Jun 30, 2021
7.39B 7.3B 7.14B 6.95B 6.72B 6.51B 6.51B 6.71B 6.86B 6.72B 6.39B
6.5B 6.1B 5.53B 2.24B 2.54B 5.97B 5.95B 5.93B 5.82B 5.45B 5.06B
884.1M 1.2B 1.61B 4.71B 4.19B 546.8M 557.3M 783.2M 1.03B 1.27B 1.33B
884.1M 1.14B 1.11B 726.2M 654.4M 546.8M 557.3M 783.2M 1.03B 1.27B 1.33B
43M 35M – 15M 15M 20.2M 21.4M 1.2M – – –
726.8M 654.1M 599.5M 553.6M 504M 422.9M 575M 779M 900.8M 1.05B 1.12B
530.4M 475M 432.3M 406.4M 379.5M 310.3M 452M 610.2M 676.8M 782.6M 860.3M
– 27.9M 27.9M 57.6M 95.35M 67.85M 63.9M 64.1M 58.45M 57.4M 59.15M
– – – – – – – – – – –
– 27.9M 97.3M 3.93B 3.86B – -898.78M -1.8B -1.75B -1.71B -1.58B
– 55.8M 125.2M 3.99B 4.15B 414.05M 317.9M 320.65M 375.8M 378.85M 348.1M
184.4M 166M 137.7M 153.1M 147.7M 118.7M 122M 93.4M 50.15M 47.5M 49.65M
– – – – – – – – – – –
6.5B 6.16B 5.66B 5.84B 6.07B 5.97B 5.95B 5.93B 5.82B 5.45B 5.06B
199.4M 181.1M 167.4M 149.1M 128M 115.5M 127.2M 174.2M 226.6M 273.6M 260.8M
175.5M 180M 188.5M 187.82M 193M 192.03M 192.9M 192.52M 192.3M 192.21M 191M
183.7M 187M 188.5M 193.67M 195.2M 197.61M 198.2M 197.98M 200M 200.15M 201M
3 2.59 2.30 2.13 1.97 1.62 2.35 3.17 3.52 4.09 4.51
2.87 2.54 2.27 2.09 1.93 1.56 2.28 3.07 3.38 3.90 4.33
1.49B 1.29B 1.28B 1.39B 1.32B 1.21B 1.32B 1.53B 1.63B 1.81B 1.86B
918.7M 657.4M 560M 695.3M 640.3M 541.6M 697M 918.1M 1.03B 1.26B 1.33B
571.6M 630M 718.6M 691.4M 682.8M 664.3M 623.5M 608.9M 595.6M 548.3M 530.3M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.